Copyright
©The Author(s) 2020.
World J Diabetes. Aug 15, 2020; 11(8): 358-369
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.358
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.358
Table 2 Syringe volume and needle length and gauge
| Syringe volume (n = 37) | |||||
| 1 mL/cc | 0.5 mL/cc | 0.3 mL/cc | |||
| Percentage | 42.9 (n = 15) | 34.3 (n = 12) | 22.9 (n = 8) | ||
| Needle length (n = 33) | |||||
| 5/16” (8 mm) | 3/16” (5 mm) | 1/8” (4 mm) | |||
| Percentage | 36.4 (n = 12) | 48.5 (n = 16) | 15.2 (n = 5) | ||
| Needle gauge (n = 32) | |||||
| 28 | 29 | 30 | 31 | ||
| Percentage | 43.8 (n = 14) | 15.6 (n = 5) | 15.6 (n = 5) | 25.0 (n = 8) | |
- Citation: Klatman EL, Ogle GD. Access to insulin delivery devices and glycated haemoglobin in lower-income countries. World J Diabetes 2020; 11(8): 358-369
- URL: https://www.wjgnet.com/1948-9358/full/v11/i8/358.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i8.358